Work

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

Year: 2007

Type: article

Source: Nature

DOI: 10.1038/nature05844

Authors: Masato Furuhashi, Gürol Tuncman, Cem Z. Görgün, Liza Makowski, Genichi Atsumi, Eric Vaillancourt, Keita Kono, Vladimir R. Babaev, Sergio Fazio, MacRae F. Linton, Richard Sulsky, Jeffrey A. Robl, Rex A. Parker, Gökhan S. Hotamisligil

Institutions: Harvard University, Duke University, Duke Medical Center, Teikyo University, Vanderbilt University, Vanderbilt University Medical Center, Bristol-Myers Squibb (United States)

Language: English

Topic: Adipokines, Inflammation, and Metabolic Diseases

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Diabetes Association, Iacocca Family Foundation, Bristol-Myers Squibb, National Institutes of Health, Japan Society for the Promotion of Science, National Heart, Lung, and Blood Institute

Award: Role of Fatty Acid Binding Proteins in Lipid Signaling

OpenAlex ID: W2067187286

FWCI: 25.02

Cites: 30

Cited by: 736

Related to: 10